“…Colchicine, which is a compound capable of inhibiting the accumulation of collagen by blocking the conversion of procollagen to collagen, has been ineffective in treating the cutaneous aspect of scleroderma in our patient. The effect of colchicine has been evaluated in some very old, short-term trials, most of which deemed it as negative 16 17. A study had suggested improvement in 19 patients (15 with diffuse disease) treated for 19–57 months with Colchicine, however, there was no comparison with a control group 18…”